Search results
Results from the WOW.Com Content Network
Now Goop has created a supplement designed to increase a woman’s libido. The new capsules, appropriately named “DTF,” are formulated to enhance women’s sexual desire, arousal and mood ...
For erectile dysfunction, men have plenty of drugs to choose from, including Cialis, Levitra, Stendra and Viagra, otherwise known as the “little blue pill.” For women, the treatment options ...
Other treatments for low libido. Women in midlife might also experience pelvic floor dysfunction, which can cause pain. In those cases, patients might need to work with a pelvic floor physical ...
Flibanserin, sold under the brand name Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD). [4] [5] The medication improves sexual desire, increases the number of satisfying sexual events, and decreases the distress associated with low sexual desire. [6]
Flibanserin [1] and Bremelanotide [3] were developed for raising sexual desire in women, whereas similar conditions in men are treated using medications for sexual dysfunction. [4] On the other hand, down-regulation on libido comes in two approaches: a direct or an indirect mechanism. Multiple drugs from each category have been proven effective ...
The justification behind this, she says, is that "the branding of Viagra has succeeded so thoroughly in rationalizing the idea of sexual correction and enhancement through pills that it seems inevitable and only fair that such a product be made available for women," giving a dangerous appeal to "nonapproved drugs though off-label prescribing". [21]
Before anyone starts taking supplements to address concerns around sex drive, Karram says it’s important to seek out a health care professional who can “ask you questions about your symptoms ...
Systematic reviews and meta-analyses of research on variation during the menstrual cycle of women's sexual activity with partners and the effects of the use of the combined oral contraceptive pill (COCP) by women on their sexual desire show that sexual desire is self-reported to be unchanged in most women taking COCPs, but also conclude that ...